PCMA: New CBO Analysis Confirms Independent Pharmacy 'Collective Bargaining' Legislation Increases Costs for Consumers and Payors

U.S. Newswire, January, 2008

To: POLITICAL EDITORS

Contact: Charles Cote of the Pharmaceutical Care Management Association, 1-202-207-3605

WASHINGTON, Jan. 15 /PRNewswire-USNewswire/ -- The Pharmaceutical Care Management Association (PCMA) issued the following statement in response to a new analysis released by the Congressional Budget Office (CBO) that estimates the costs associated with sweeping antitrust exemptions for independent pharmacies:

"The new CBO analysis confirms that sweeping antitrust exemptions for independent pharmacies would increase costs for Medicare Part D, Medicaid, the Federal Employees Health Benefits (FEHB) program, as well as for employers and consumers. HR 971 would give independent pharmacies a 'license to collude' to raise prescription drug prices, without...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement